The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Fatty acid synthesis: a potential selective target for antineoplastic therapy
Open accessAbstract
OA-519 is a prognostic molecule found in tumor cells from breast cancer patients with markedly worsened prognosis. We purified OA-519 from human breast carcinoma cells, obtained its peptide sequence, and unambiguously identified it as fatty acid synthase through sequence homology and enzymology. Tumor fatty acid synthase is an approximately 270-kDa polypeptide which specifically abolished immunostaining of human breast cancers by anti-OA-519 antibodies. Tumor fatty acid synthase oxidized NADPH in a malonyl-CoA-dependent fashion and synthesized fatty acids composed of 80% palmitate, 10% myristate, and 10% stearate from acetyl-CoA, malonyl-CoA, and NADPH with a specific activity of 624 nmol of NADPH oxidized per min per mg. Tumor cell lines with elevated fatty acid synthase showed commensurate increases in incorporation of [U-14C]acetate into acylglycerols demonstrating that fatty acid synthase increases occur in the context of overall increases in endogenous fatty acid synthesis. Cerulenin inhibited acylglycerol synthesis in tumor cells and fibroblast controls in a dose-dependent fashion and also caused a growth inhibition which generally paralleled the level of endogenous fatty acid synthesis. Supraphysiologic levels of palmitate, 14 microM in dimethyl sulfoxide, significantly reversed the growth inhibition caused by cerulenin at concentrations of up to 5 micrograms/ml, indicating that cerulenin-mediated growth inhibition was due to fatty acid synthase inhibition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Cleveland, D. W., Fischer, S. G., Kirschner, M. W., & Laemmli, U. K. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)75212-0 · Cited by 5,556
Fatty acid synthase, a proficient multifunctional enzyme
Wakil, S. J. (1989) · Biochemistry · doi:10.1021/bi00437a001 · Cited by 823
A Practical Guide to Protein and Peptide Purification for Microsequencing
(1993) · Elsevier eBooks · doi:10.1016/c2009-0-03542-9 · Cited by 502
The antibiotic cerulenin, a novel tool for biochemistry as an inhibitor of fatty acid synthesis
Ōmura, S. (1976) · Bacteriological Reviews · doi:10.1128/br.40.3.681-697.1976 · Cited by 403
Fletcher, J., Spector, A. A., & Ashbrook, J. D. (1971) · Biochemistry · doi:10.1021/bi00793a011 · Cited by 270
Stremmel, W., Strohmeyer, G. W., & Berk, P. D. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.11.3584 · Cited by 210
WEISS, L., HOFFMANN, G. E., Schreiber, R., Andres, H. H., Fuchs, E., KÖRBER, E., & Kolb, H. J. (1986) · Biological Chemistry Hoppe-Seyler · doi:10.1515/bchm3.1986.367.2.905 · Cited by 190
Binding Site of Cerulenin in Fatty Acid Synthetase1
Funabashi, H., Kawaguchi, A., Tomoda, H., Ōmura, S., Okuda, S., & Iwasaki, S. (1989) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a122739 · Cited by 179
Effects of free fatty acids on the growth of normal and neoplastic rat mammary epithelial cells.
Wicha, M. S., Liotta, L. A., & Kidwell, W. R. (1979) · PubMed · Cited by 169
Molecular cloning and sequencing of cDNAs encoding the entire rat fatty acid synthase.
Amy, C. M., Witkowski, A., Naggert, J. Κ., Williams, B., Randhawa, Z. I., & Smith, S. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.9.3114 · Cited by 161
Cited by
Sorted by citations
Items 201–300 of 718
The acetyl-CoA carboxylase enzyme: a target for cancer therapy?
Wang, C., Ma, J., Zhang, N., Yang, Q., Jin, Y., & Wang, Y. (2015) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2015.1038246 · Cited by 87
Zagani, R., El-Assaad, W., Gamache, I., & Teodoro, J. G. (2015) · Oncotarget · doi:10.18632/oncotarget.5061 · Cited by 88
Photoacoustic imaging as a tool to probe the tumour microenvironment
Brown, E. L., Brunker, J., & Bohndiek, S. E. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.039636 · Cited by 87
Angerer, T. B., Magnusson, Y., Landberg, G., & Fletcher, J. S. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.6b03884 · Cited by 89
"Spot 14" Protein: A Metabolic Integrator in Normal and Neoplastic Cells
Cunningham, B. A., Moncur, J. T., Huntington, J., & Kinlaw, W. B. (1998) · Thyroid · doi:10.1089/thy.1998.8.815 · Cited by 85
Fatty acid synthase regulates estrogen receptor-α signaling in breast cancer cells
Menéndez, J., & Lupu, R. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.4 · Cited by 76
Menéndez, J. A., Decker, J. P., & Lupu, R. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20310 · Cited by 84
Menéndez, J. A., Mehmi, I., Verma, V. A., Teng, P. K., & Lupu, R. (2004) · Molecular Carcinogenesis · doi:10.1002/mc.20054 · Cited by 84
Rutin and orlistat produce antitumor effects via antioxidant and apoptotic actions
Saleh, A. A., El‐Fayoumi, H. M., Youns, M., & Barakat, W. (2018) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-018-1579-0 · Cited by 83
Chuang, H., Chang, Y.-F., & Hwang, J. (2011) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2011.02.016 · Cited by 83
Lee, J., Lee, M. S., Oh, W. K., & Sul, J. Y. (2009) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.32.1427 · Cited by 83
Kaznowska, E. B., Depciuch, J., Łach, K., Kołodziej, M., Koziorowska, A. M., Vongsvivut, J. P., Zawlik, I., Cholewa, M., & Cebulski, J. (2018) · Talanta · doi:10.1016/j.talanta.2018.04.083 · Cited by 82
Menéndez, J. A., Lupu, R., & Colomer, R. (2004) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000018409.59448.60 · Cited by 82
Molecular mechanisms of fatty acid synthase (FASN)-mediated resistance to anti-cancer treatments
Wu, X., Qin, L., Fako, V., & Zhang, J.-T. (2014) · Advances in Biological Regulation · doi:10.1016/j.jbior.2013.09.004 · Cited by 82
Menéndez, J. A., Vellón, L., & Lupu, R. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.09.027 · Cited by 82
The autophagy conundrum in cancer: influence of tumorigenic metabolic reprogramming
Eng, C. H., & Abraham, R. T. (2011) · Oncogene · doi:10.1038/onc.2011.220 · Cited by 83
Splicing factor ESRP1 controls ER‐positive breast cancer by altering metabolic pathways
Gökmen‐Polar, Y., Neelamraju, Y., Goswami, C. P., Gu, Y., Gu, X., Nallamothu, G., Vieth, E., Janga, S. C., Ryan, M., & Badve, S. (2019) · EMBO Reports · doi:10.15252/embr.201846078 · Cited by 81
Polyunsaturated fatty acid metabolism in prostate cancer
Berquin, I. M., Edwards, I. J., Kridel, S. J., & Chen, Y. Q. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9299-7 · Cited by 81
Yamashita, Y., Kumabe, T., Cho, Y., Watanabe, M., Kawagishi, J., Yoshimoto, T., Fujino, T., Kang, M., & Yamamoto, T. T. (2000) · Oncogene · doi:10.1038/sj.onc.1203981 · Cited by 80
Purohit, V. C., Richardson, R. D., Smith, J. W., & Romo, D. (2006) · The Journal of Organic Chemistry · doi:10.1021/jo060392d · Cited by 80
Lipin-1 regulates cancer cell phenotype and is a potential target to potentiate rapamycin treatment
Brohée, L., Demine, S., Willems, J., Arnould, T., Colige, A., & Deroanne, C. (2015) · Oncotarget · doi:10.18632/oncotarget.3595 · Cited by 80
Hypoxia induces a lipogenic cancer cell phenotype via HIF1α-dependent and -independent pathways
Valli, A., Rodriguez, M., Moutsianas, L., Fischer, R., Fedele, V., Huang, H.-L., Van Stiphout, R., Jones, D., Mccarthy, M., Vinaxia, M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3058 · Cited by 79
Zeng, L., Wu, G., Goh, K. J., Lee, Y. M., Ng, C. C., You, A. B., Wang, J., Jia, D., Hao, A., Yu, Q., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002329 · Cited by 78
Yeast and cancer cells – common principles in lipid metabolism
Natter, K., & Kohlwein, S. D. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.09.003 · Cited by 78
Ueda, S. M., Yap, K. L., Davidson, B., Tian, Y., Murthy, V. K., Wang, T., Visvanathan, K., Kuhajda, F. P., Bristow, R. E., Zhang, H., et al. (2010) · Journal of Oncology · doi:10.1155/2010/285191 · Cited by 78
Self-citationAndrogens and the control of lipid metabolism in human prostate cancer cells
Swinnen, J. V., & Verhoeven, G. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)00187-8 · Cited by 78
Brockmöller, S. F., Bucher, E., Müller, B. M., Budczies, J., Hilvo, M., Griffin, J. L., Orešič, M., Kallioniemi, O., Iljin, K., Loibl, S., et al. (2011) · Journal of Proteome Research · doi:10.1021/pr200685r · Cited by 77
Fatty Acid Metabolism, the Central Nervous System, and Feeding
Ronnett, G. V., Kleman, A. M., Kim, E. K., Landree, L. E., & Tu, Y. (2006) · Obesity · doi:10.1038/oby.2006.309 · Cited by 81
The diverse role of the PPARγ coactivator 1 family of transcriptional coactivators in cancer
Girnun, G. D. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2012.01.007 · Cited by 76
Fatty acid synthase is a marker of increased risk of recurrence in endometrial carcinoma
Sebastiani, V. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2003.10.027 · Cited by 75
Khan, A., Aljarbou, A. N., Aldebasi, Y. H., Faisal, S. M., & Khan, M. A. (2014) · Cancer Epidemiology · doi:10.1016/j.canep.2014.09.006 · Cited by 77
Why does tumor-associated fatty acid synthase (oncogenic antigen-519) ignore dietary fatty acids?
Menéndez, J. A., Colomer, R., & Lupu, R. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.07.022 · Cited by 75
Fatty acid synthase causes drug resistance by inhibiting TNF-α and ceramide production
Liu, H., Wu, X., Dong, Z., Luo, Z., Zhao, Z., Xu, Y., & Zhang, J. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m033811 · Cited by 75
The BRG1 chromatin remodeling enzyme links cancer cell metabolism and proliferation
Wu, Q., Madany, P., Dobson, J. R., Schnabl, J. M., Sharma, S., Smith, T. C., van Wijnen, A. J., Stein, J. L., Lian, J. B., Stein, G. S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9505 · Cited by 76
Evidence of aberrant lipid metabolism in hepatitis C and hepatocellular carcinoma
Wu, J.-M., Skill, N. J., & Maluccio, M. A. (2010) · HPB · doi:10.1111/j.1477-2574.2010.00207.x · Cited by 73
Verge, J., Guix, J. M. M., Alejo, M., Basas, C., Quer, X., Castro, J. D., Autonell, J. V., & Serra, C. (1999) · Head & Neck · doi:10.1002/(sici)1097-0347(199907)21:4 · Cited by 95
Possible adjuvant cancer therapy by two prebiotics--inulin or oligofructose.
Taper, H. S., & Roberfroid, M. B. (2005) · PubMed · Cited by 72
Bagnato, C., & Igal, R. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305760200 · Cited by 72
Fatty acid synthase is preferentially degraded by autophagy upon nitrogen starvation in yeast
Shpilka, T., Welter, E., Borovsky, N., Amar, N., Shimron, F., Peleg, Y., & Elazar, Z. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409476112 · Cited by 72
Hypothalamic lipotoxicity and the metabolic syndrome
de Morentin, P. B. M., Varela, L., Fernø, J., Nogueiras, R., Diéguez, C., & López, M. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.09.016 · Cited by 73
Chavarro, J. E., Kenfield, S. A., Stampfer, M. J., Loda, M. F., Campos, H., Sesso, H. D., & Ma, J. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kwt136 · Cited by 71
Mottaz, A. E., Markwalder, R. V., Fey, M. F., Klima, I., Merz, V. W., Thalmann, G. N., Ball, R. K., & Studer, U. E. (1997) · The Prostate · doi:10.1002/(sici)1097-0045(19970601)31:4 · Cited by 32
Bollu, L. R., Ren, J., Blessing, A. M., Katreddy, R. R., Gao, G., Xu, L., Wang, J., Su, F., & Weihua, Z. (2014) · Cell Cycle · doi:10.4161/cc.29338 · Cited by 69
Fatty acid synthase inhibits the O-GlcNAcase during oxidative stress
Groves, J. A., Maduka, A. O., O’Meally, R. N., Cole, R. N., & Zachara, N. E. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.760785 · Cited by 69
Lee, H. J., Ryu, J. M., Jung, Y. H., Oh, S. Y., Lee, S., & Han, H. J. (2015) · Stem Cells · doi:10.1002/stem.2020 · Cited by 68
New Synthetic Inhibitors of Fatty Acid Synthase with Anticancer Activity
Turrado, C., Puig, T., Garcı́a-Cárceles, J., Artola, M., Benhamú, B., Ortega‐Gutiérrez, S., Relat, J., Oliveras, G., Blancafort, A., Haro, D., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm2016045 · Cited by 68
Vazquez-Martin, A., Ropero, S., Brunet, J., Colomer, R., & Menéndez, J. A. (2007) · Oncology Reports · doi:10.3892/or.18.4.973 · Cited by 67
Yancy, H. F., Mason, J. A., Peters, S. M., Thompson, C. E., Littleton, G. K., Jett, M., & Day, A. A. (2007) · Journal of Carcinogenesis · doi:10.1186/1477-3163-6-8 · Cited by 67
Glycerophospholipid Synthesis as a Novel Drug Target Against Cancer
Dolce, V., Cappello, A. R., Lappano, R., & Maggiolini, M. (2011) · Current Molecular Pharmacology · doi:10.2174/1874-470211104030167 · Cited by 69
Moncur, J. T., Park, J. P., Memoli, V. A., Mohandas, T. K., & Kinlaw, W. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6989 · Cited by 67
Harris, D. M., Li, L., Chen, M. F., Lagunero, F. T., Go, V. L. W., & Boros, L. G. (2011) · Metabolomics · doi:10.1007/s11306-011-0300-9 · Cited by 66
Structure of the Human Fatty Acid Synthase KS–MAT Didomain as a Framework for Inhibitor Design
Pappenberger, G., Benz, J., Gsell, B., Hennig, M., Ruf, A., Stihle, M., Thoma, R., & Rudolph, M. G. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.01.066 · Cited by 66
Lee, J., & Welch, D. R. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970611)71:6 · Cited by 174
Inhibition of fatty acid synthase is protective in pulmonary hypertension
Singh, N., Manhas, A., Kaur, G., Jagavelu, K., & Hanif, K. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13495 · Cited by 63
Fatty acid synthase expression in cutaneous melanocytic neoplasms
Kapur, P., Rakheja, D., Roy, L., & Hoang, M. P. (2005) · Modern Pathology · doi:10.1038/modpathol.3800395 · Cited by 65
Zhan, Y., Ginanni, N., Tota, M. R., Wu, M. S., Bays, N. W., Richon, V. M., Kohl, N. E., Bachman, E. S., Strack, P. R., & Krauss, S. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5074 · Cited by 68
Radicicol Binds and Inhibits Mammalian ATP Citrate Lyase
Ki, S. W., Ishigami, K., Kitahara, T., Kasahara, K., Yoshida, M., & Horinouchi, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006192200 · Cited by 66
Chaturvedi, D., Andugulapati, S. B., Bn, V., Ariese, F., Umapathy, S., & Rangarajan, A. (2016) · Biosensors · doi:10.3390/bios6040057 · Cited by 64
Pflug, B. R., Pecher, S., Brink, A. W., Nelson, J. B., & Foster, B. A. (2003) · The Prostate · doi:10.1002/pros.10297 · Cited by 63
Inulin/oligofructose and anticancer therapy
Taper, H., & Roberfroid, M. B. (2002) · British Journal Of Nutrition · doi:10.1079/bjn/2002549 · Cited by 63
Trypanosome lytic factors: novel mediators of human innate immunity
Raper, J. (2001) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(00)00226-5 · Cited by 63
Elovl6 is a poor prognostic predictor in breast cancer
FENG, Y.-H., CHEN, W.-Y., Kuo, Y.-H., Tung, C., Tsao, C., Shiau, A., & Wu, C. (2016) · Oncology Letters · doi:10.3892/ol.2016.4587 · Cited by 62
Deepa, P. R., Vandhana, S., Jayanthi, U., & Krishnakumar, S. (2011) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2011.00844.x · Cited by 62
Júnior, F. C. A. D. A., Kowalski, L. P., & de Almeida, O. P. (2006) · Oral Oncology · doi:10.1016/j.oraloncology.2006.07.003 · Cited by 62
Regulation of Stem Cell Fate by ROS-mediated Alteration of Metabolism
Ryu, J. M., Lee, H. J., Jung, Y. H., Lee, K. H., Kim, D. I., Kim, J. Y., Ko, S. H., Choi, G. E., Chai, I. I., Song, E. J., et al. (2015) · International Journal of Stem Cells · doi:10.15283/ijsc.2015.8.1.24 · Cited by 62
Kwan, H. Y., Yang, Z., Fong, W. F., Hu, Y., Yu, Z., & Hsiao, W. L. W. (2012) · Journal of Gastroenterology · doi:10.1007/s00535-012-0612-1 · Cited by 61
Fatostatin induces pro- and anti-apoptotic lipid accumulation in breast cancer
Brovkovych, V. M., Izhar, Y., Danes, J. M., Dubrovskyi, O., Sakallioglu, I. T., Morrow, L. M., Atilla‐Gokcumen, G. E., & Frasor, J. M. (2018) · Oncogenesis · doi:10.1038/s41389-018-0076-0 · Cited by 61
Feider, C. L., Macias, L. A., Brodbelt, J. S., & Eberlin, L. S. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c00970 · Cited by 61
Endometriotic Lesions Synthesize and Secrete a Haptoglobin-Like Protein1
Sharpe-Timms, K. L., Piva, M. A., Ricke, E. A., Surewicz, K. A., Zhang, Y. L., & Zimmer, R. L. (1998) · Biology of Reproduction · doi:10.1095/biolreprod58.4.988 · Cited by 61
Key role of mitochondria in cerulenin-mediated apoptosis
Heiligtag, S., Bredehorst, R., & David, K. A. (2002) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401055 · Cited by 59
Deng, B., Kong, W., Shen, X., Han, C. Q., Zhao, Z., Chen, S., Zhou, C., & Bae-Jump, V. L. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05084-z · Cited by 63
Na, M., Jang, J., Min, B. S., Lee, S. J., Lee, M. S., Kim, B. Y., Oh, W. K., & Ahn, J. S. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.07.018 · Cited by 60
Chang, L., Fang, S., Chen, Y., Yang, Z., Yuan, Y., Zhang, J., Ye, L., & Gu, W. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1058-8 · Cited by 64
Metabolism and immunity in breast cancer
Zhang, D., Xu, X., & Ye, Q. (2020) · Frontiers of Medicine · doi:10.1007/s11684-020-0793-6 · Cited by 58
Zhang, I., Cui, Y., Amiri, A., Ding, Y., Campbell, R. E., & Maysinger, D. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.12.008 · Cited by 59
Fatty Acids and Breast Cancer: Make Them on Site or Have Them Delivered
Kinlaw, W. B., Baures, P. W., Lupien, L. E., Davis, W. L., & Kuemmerle, N. B. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25332 · Cited by 59
Liao, C., Chen, S., Huang, H., & Wang, C. (2017) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2017.06.006 · Cited by 59
Elevated Expression of DecR1 Impairs ErbB2/Neu-Induced Mammary Tumor Development
Ursini‐Siegel, J., Rajput, A. B., Lu, H., Sanguin‐Gendreau, V., Zuo, D., Papavasiliou, V., Lavoie, C. A., Turpin, J., Cianflone, K., Huntsman, D. D., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00686-07 · Cited by 58
Inhibition of ATP Citrate Lyase Induces an Anticancer Effect via Reactive Oxygen Species
Migita, T., Okabe, S., Ikeda, K., Igarashi, S., Sugawara, S., Tomida, A., Taguchi, R., Soga, T., & Seimiya, H. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.01.048 · Cited by 58
Rovadoscki, G. A., Pértile, S. F. N., Alvarenga, A. B., César, A. S. M., Pértille, F., Petrini, J., Franzo, V., Soares, W. V. B., Morota, G., Spangler, M. L., et al. (2018) · BMC Genomics · doi:10.1186/s12864-018-4777-8 · Cited by 56
Fatty Acid Synthesis in Glial Cells of the CNS
Corrales, A. V. G., Haidar, M., Bogie, J. F. J., & Hendriks, J. J. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158159 · Cited by 59
Pathogenesis of Ovarian Cancer: Clues from Selected Overexpressed Genes
Shih, I., & Davidson, B. (2009) · Future Oncology · doi:10.2217/fon.09.126 · Cited by 56
3-Aryl-4-hydroxyquinolin-2(1H)-one derivatives as type I fatty acid synthase inhibitors
Rivkin, A., Kim, Y. R., Goulet, M. T., Bays, N. W., Hill, A. D., Kariv, I., Krauss, S., Ginanni, N., Strack, P. R., Kohl, N. E., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.06.014 · Cited by 55
Selvendiran, K., Ahmed, S., Dayton, A., Ravi, Y., Kuppusamy, M. L., Bratasz, A., Rivera, B. K., Kálai, T., Hideg, K., & Kuppusamy, P. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0201 · Cited by 55
De novo lipogenesis represents a therapeutic target in mutant Kras non‐small cell lung cancer
Singh, A., Ruiz, C. F., Bhalla, K., Haley, J. D., Li, Q. K., Acquaah-Mensah, G. K., Montal, E. D., Sudini, K. R., Skoulidis, F., Wistuba, I. I., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201800204 · Cited by 60
Chen, H.-W., Chang, Y.-F., Chuang, H.-Y., Tai, W.-T., & Hwang, J.-J. (2012) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2012.15 · Cited by 54
Acyl-CoA Synthetase VL3 Knockdown Inhibits Human Glioma Cell Proliferation and Tumorigenicity
Pei, Z., Sun, P., Huang, P. C., Lal, B., Laterra, J., & Watkins, P. A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4689 · Cited by 54
Lipid metabolism enzyme ACSVL3 supports glioblastoma stem cell maintenance and tumorigenicity
Sun, P., Xia, S., Lal, B., Shi, X., Yang, K. S., Watkins, P. A., & Laterra, J. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-401 · Cited by 54
Inhibition of Coix seed extract on fatty acid synthase, a novel target for anticancer activity
Yu, F., Gao, J., Zeng, Y., & Liu, C. (2008) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2008.07.015 · Cited by 54
Hashimoto, T., Kusakabe, T., Sugino, T., Fukuda, T., Watanabe, K., Sato, Y., Nashimoto, A., Honma, K., Kimura, H., Fujii, H., et al. (2004) · Pathobiology · doi:10.1159/000080061 · Cited by 53
Lipid Biosynthesis and its Coordination with Cell Cycle Progression
Kwok, A. C. M., & Wong, J. T. Y. (2005) · Plant and Cell Physiology · doi:10.1093/pcp/pci213 · Cited by 53
Hypothalamic malonyl-CoA and the control of food intake
Gao, S., Moran, T. H., Lopaschuk, G. D., & Butler, A. A. (2013) · Physiology & Behavior · doi:10.1016/j.physbeh.2013.07.014 · Cited by 56
Abnormal fatty acid distribution of the serum phospholipids of patients with non-Hodgkin lymphoma
Cvetković, Z., Vučić, V., Cvetkovic, B., Petrović, M., Ristić-Medić, D., Tepšić, J., & Glibetić, M. (2010) · Annals of Hematology · doi:10.1007/s00277-010-0904-6 · Cited by 52
Fortschritte in der Chemie und Biologie natürlicher Antibiotika
Nicolaou, K. C., Chen, J. S., Edmonds, D. J., & Estrada, A. A. (2009) · Angewandte Chemie · doi:10.1002/ange.200801695 · Cited by 52
Membrane fatty acids of breast carcinoma: Contribution of host fatty acids and tumor properties
Chajès, V., Lanson, M., Fetissof, F., Lhuillery, C., & Bougnoux, P. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910630204 · Cited by 52
Altered Lipid Tumor Environment and Its Potential Effects on NKT Cell Function in Tumor Immunity
Tiwary, S., Berzofsky, J. A., & Terabe, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02187 · Cited by 54
Lipogenic effects of androgen signaling in normal and malignant prostate
Mah, C. Y., Nassar, Z. D., Swinnen, J. V., & Butler, L. M. (2019) · Asian journal of urology · doi:10.1016/j.ajur.2019.12.003 · Cited by 59
Antimycobacterial activity of cerulenin and its effects on lipid biosynthesis
Parrish, N. M. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.2.219 · Cited by 51
Mir, S. A., Rajagopalan, P., Jain, A., Khan, A. A., Datta, K. K., Mohan, S. V., Lateef, S. S., Sahasrabuddhe, N. A., Somani, B. L., Prasad, T. S. K., et al. (2015) · Journal of Proteomics · doi:10.1016/j.jprot.2015.05.013 · Cited by 50
Nashed, M., Chisholm, J. W., & Igal, R. A. (2012) · Experimental Biology and Medicine · doi:10.1258/ebm.2012.012126 · Cited by 50
Metadata
- Authors
- Kuhajda, F. P., Jenner, K., Wood, F. D., Hennigar, R. A., Jacobs, L. B., Dick, J. D., & Pasternack, G. R.
- Affiliations
- Johns Hopkins University (US)
- ORCID
- Hennigar, R A
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1994-07-05
- Volume
- 91
- Issue
- 14
- Pages
- 6379-6383
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC44205
- OpenAlex
- W2090846942
- Cited by
- 705
- References
- 26
- Citations by year
- 2026: 13 · 2025: 13 · 2024: 12 · 2023: 32 · 2022: 33 · 2021: 30 · 2020: 19 · 2019: 29 · 2018: 18 · 2017: 31 · 2016: 39 · 2015: 28 · 2014: 38 · 2013: 33 · 2012: 36
- FWCI
- 3.94
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Keywords
- fatty acid synthase, breast cancer, cerulenin, antineoplastic therapy, fatty acid synthesis, palmitate, NADPH oxidation, malonyl-CoA, tumor growth inhibition
- MeSH terms
- Acetates, Antibodies, Antigens, Neoplasm, Blood Proteins, Breast Neoplasms, Carbon Radioisotopes, Cell Division, Cell Line, Cerulenin, Fatty Acids, Female, Haptoglobins, Humans, Immunohistochemistry, Kinetics, Malonyl Coenzyme A, Palmitic Acids, Prognosis, Tumor Cells, Cultured, Biomarkers, Tumor, Drug Design, Palmitic Acid, Fatty Acid Synthases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review